Ultrasound-Induced Blood-Spinal Cord Barrier Opening in Rabbits

Ultrasound Med Biol. 2019 Sep;45(9):2417-2426. doi: 10.1016/j.ultrasmedbio.2019.05.022. Epub 2019 Jun 24.

Abstract

The blood-spinal cord barrier (BSCB) considerably limits the delivery and efficacy of treatments for spinal cord diseases. The blood-brain barrier can be safely opened with low-intensity pulsed ultrasound when microbubbles are simultaneously administered intravenously. This technique was tested on the BSCB in a rabbit model in this work. Twenty-three segments of spinal cord were sonicated with a 1-MHz unfocused pulsed ultrasound device and compared with non-sonicated segments. BSCB disruption was assessed using Evan's blue dye (EBD) extravasation. Tolerance was assessed by histologic analysis. An increased EBD concentration indicating BSCB disruption was clearly observed in sonicated segments compared with controls (p = 0.004). On one animal, which received 10 sonications, repetitive BSCB disruptions revealed no evidence of cumulative toxicity. BSCB can be disrupted using an unfocused pulsed ultrasound device in combination with microbubbles without neurotoxicity even in case of repeated sonications.

Keywords: Blood–brain barrier; Blood–spinal cord barrier; Drug delivery; Spinal cord; Ultrasound.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Contrast Media / pharmacokinetics
  • Evans Blue / pharmacokinetics
  • Microbubbles
  • Models, Animal
  • Phospholipids / pharmacokinetics
  • Rabbits
  • Spinal Cord / metabolism*
  • Sulfur Hexafluoride / pharmacokinetics
  • Ultrasonics / methods*

Substances

  • Contrast Media
  • Phospholipids
  • contrast agent BR1
  • Evans Blue
  • Sulfur Hexafluoride